Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan

被引：0
|
作者：
Morihiko Kimura
Takeshi Tominaga
Yuichi Takatsuka
Masakazu Toi
Rikiya Abe
Hiroki Koyama
Shigemitsu Takashima
Yasuo Nomura
Shigeto Miura
Izo Kimijima
Hideya Tashiro
Yasuo Ohashi
机构：
[1] Gunma Prefectural Cancer Center,Department of Surgery
[2] Showa University Toyosu Hospital,Department of Surgery
[3] Kansai Rosai Hospital,Department of Surgery
[4] Komagome Hospital,Department of Surgery
[5] Fukushima Medical University,Department of Surgery
[6] Osaka Medical Center for Cancer and Cardiovascular Diseases,Department of Surgery
[7] National Shikoku Cancer Center,Department of Surgery
[8] National Kyushu Cancer Center,Department of Surgery
[9] Aichi Cancer Center,Department of Surgery
[10] Matsuyama Red Cross Hospital,Department of Biostatistics
[11] Tokyo University,undefined
[12] General Ota Hospital,undefined
来源：
Breast Cancer | 2010年 / 17卷
关键词：
Breast cancer; Post-operative; Adjuvant; Chemotherapy; CEF; CMF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：190 / 198
页数：8
相关论文
共 50 条
  • [1] Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
    Kimura, Morihiko
    Tominaga, Takeshi
    Takatsuka, Yuichi
    Toi, Masakazu
    Abe, Rikiya
    Koyama, Hiroki
    Takashima, Shigemitsu
    Nomura, Yasuo
    Miura, Shigeto
    Kimijima, Izo
    Tashiro, Hideya
    Ohashi, Yasuo
    [J]. BREAST CANCER, 2010, 17 (03) : 190 - 198
  • [2] Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer
    Levine, MN
    Bramwell, VH
    Pritchard, KI
    Norris, BD
    Shepherd, LE
    Abu-Zahra, H
    Findlay, B
    Warr, D
    Bowman, D
    Myles, J
    Arnold, A
    Vandenberg, T
    MacKenzie, R
    Robert, J
    Ottaway, J
    Burnell, M
    Williams, CK
    Tu, DS
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2651 - 2658
  • [3] Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: Results of a randomized trial
    Coombes, RC
    Bliss, JM
    Wils, J
    Morvan, F
    Espie, M
    Amadori, D
    Gambrosier, P
    Richards, M
    Aapro, M
    VillarGrimalt, A
    McArdle, C
    PerezLopez, FR
    Vassilopoulos, P
    Ferreira, EP
    Chilvers, CED
    Coombes, G
    Woods, EM
    Marty, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 35 - 45
  • [4] Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancer
    Radice, D
    Redaelli, A
    [J]. PHARMACOECONOMICS, 2005, 23 (01) : 69 - 75
  • [5] Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer
    Piccart, MJ
    Di Leo, A
    Beauduin, M
    Vindevoghel, A
    Michel, J
    Focan, C
    Tagnon, A
    Ries, F
    Gobert, P
    Finet, C
    Closon-Dejardin, MT
    Dufrane, JP
    Kerger, J
    Liebens, F
    Beauvois, S
    Bartholomeus, S
    Dolci, S
    Lobelle, JP
    Paesmans, M
    Nogaret, JM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (12) : 3103 - 3110
  • [6] Q-TWiST analysis of cyclophosphamide, epirubicin, fluorouracil versus cyclophosphamide, methotrexate, fluorouracil treatment for premenopausal women with node-positive breast cancer
    Davide Radice
    Alberto Redaelli
    [J]. PharmacoEconomics, 2005, 23 : 69 - 75
  • [7] Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: Update of National Cancer Institute of Canada Clinical Trials Group Trial MA5
    Levine, MN
    Pritchard, KL
    Bramwell, VHC
    Shepherd, LE
    Tu, DS
    Paul, N
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5166 - 5170
  • [8] Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer - Comment
    Ost, E
    Illiger, HJ
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (01) : 54 - 55
  • [9] Erratum to: Cost-effectiveness of adjuvant chemotherapy with cyclophosphamide + methotrexate + fluorouracil in patients with node-positive breast cancer
    A. Messori
    P. Becagli
    S. Trippoli
    E. Tendi
    [J]. European Journal of Clinical Pharmacology, 1997, 51 : 427 - 427
  • [10] Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer
    Heidemann, E
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 1998, 174 (05) : 290 - 291
12345